Florida's 1st Choice Realty, led by Rene and Dana Carpena, joined eXp Realty in September 2026, bringing over $470 million in sales since 2021 and 70+ agents. The move enables expansion across multiple states using eXp's infrastructure, allowing the founders to focus on mentorship and agent growth while maintaining their brand identity. They have already sponsored agents in Georgia and Illinois and are developing a New Jersey team. This partnership offers agents access to eXp's technology and network, supporting future growth without the costs of independent expansion.
Florida's 1st Choice Realty joining eXp Realty is the subject, with Pluang market data as context. As of Nov 04, 2026 20:41 WIB, 38 of 47 priced Real Estate-sector US stocks on Pluang rose while 6 fell. Notable movers include Opendoor Technologies Inc at USD 1.86 (+6.90%), Compass Inc. Class A at USD 9.69 (+3.97%), and UDR Inc. at USD 36.97 (+2.89%).
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
